JP Morgan Chase
IHI icon

JP Morgan Chase’s iShares US Medical Devices ETF IHI Stock Holding History

JP Morgan Chase’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56M Buy
149,105
+5,395
+4% +$274K ﹤0.01% 3065
2026
Q1 		$7.56M Buy
143,710
+25,866
+22% +$1.52M ﹤0.01% 2943
2025
Q4 		$7.32M Sell
117,844
-373,030
-76% -$23M ﹤0.01% 2973
2025
Q3 		$29.5M Buy
490,874
+223,216
+83% +$13.7M ﹤0.01% 1779
2025
Q2 		$16.8M Sell
267,658
-86,094
-24% -$5.17M ﹤0.01% 2090
2025
Q1 		$21.3M Sell
353,752
-141,091
-29% -$8.76M ﹤0.01% 1886
2024
Q4 		$28.9M Sell
494,843
-707,551
-59% -$42.1M ﹤0.01% 1698
2024
Q3 		$71.2M Buy
1,202,394
+674,168
+128% +$38.5M 0.01% 1123
2024
Q2 		$29.6M Sell
528,226
-104,616
-17% -$5.86M ﹤0.01% 1563
2024
Q1 		$37.1M Buy
632,842
+79,090
+14% +$4.47M ﹤0.01% 1469
2023
Q4 		$29.9M Buy
553,752
+175,143
+46% +$8.56M ﹤0.01% 1532
2023
Q3 		$18.4M Buy
378,609
+136,604
+56% +$7.26M ﹤0.01% 1743
2023
Q2 		$13.7M Sell
242,005
-45,214
-16% -$2.49M ﹤0.01% 2017
2023
Q1 		$15.5M Sell
287,219
-27,247
-9% -$1.45M ﹤0.01% 1881
2022
Q4 		$16.5M Buy
314,466
+64,974
+26% +$3.3M ﹤0.01% 1817
2022
Q3 		$11.8M Sell
249,492
-95,555
-28% -$4.96M ﹤0.01% 2021
2022
Q2 		$17.4M Sell
345,047
-1,181,636
-77% -$64.4M ﹤0.01% 1719
2022
Q1 		$93.1M Sell
1,526,683
-985,395
-39% -$58.7M 0.01% 865
2021
Q4 		$165M Sell
2,512,078
-59,947
-2% -$3.84M 0.02% 650
2021
Q3 		$161M Buy
2,572,025
+462,329
+22% +$29.5M 0.02% 648
2021
Q2 		$127M Buy
2,109,696
+1,366,200
+184% +$79M 0.02% 787
2021
Q1 		$40.9M Sell
743,496
-80,898
-10% -$4.49M 0.01% 1253
2020
Q4 		$45M Sell
824,394
-2,357,610
-74% -$123M 0.01% 1130
2020
Q3 		$156M Buy
3,182,004
+2,752,116
+640% +$133M 0.03% 545
2020
Q2 		$19M Buy
429,888
+350,958
+445% +$15M ﹤0.01% 1401
2020
Q1 		$2.96M Sell
78,930
-18,744
-19% -$789K ﹤0.01% 2667
2019
Q4 		$4.3M Sell
97,674
-4,698
-5% -$197K ﹤0.01% 2803
2019
Q3 		$4.22M Sell
102,372
-138
-0.1% -$5.65K ﹤0.01% 2844
2019
Q2 		$4.08M Buy
102,510
+23,706
+30% +$897K ﹤0.01% 2791
2019
Q1 		$3.04M Sell
78,804
-5,148
-6% -$187K ﹤0.01% 3023
2018
Q4 		$2.79M Buy
83,952
+11,730
+16% +$406K ﹤0.01% 3037
2018
Q3 		$2.74M Buy
72,222
+2,502
+4% +$88.9K ﹤0.01% 3235
2018
Q2 		$2.33M Sell
69,720
-292,890
-81% -$9.54M ﹤0.01% 3305
2018
Q1 		$11.2M Buy
362,610
+304,560
+525% +$9.38M ﹤0.01% 1950
2017
Q4 		$1.68M Buy
58,050
+9,030
+18% +$260K ﹤0.01% 3421
2017
Q3 		$1.35M Sell
49,020
-3,528
-7% -$97.6K ﹤0.01% 3364
2017
Q2 		$1.46M Buy
52,548
+9,132
+21% +$242K ﹤0.01% 3232
2017
Q1 		$1.1M Buy
43,416
+2,004
+5% +$48.6K ﹤0.01% 3365
2016
Q4 		$919K Buy
41,412
+4,662
+13% +$106K ﹤0.01% 3486
2016
Q3 		$890K Buy
36,750
+8,964
+32% +$213K ﹤0.01% 3186
2016
Q2 		$628K Buy
27,786
+5,250
+23% +$114K ﹤0.01% 3352
2016
Q1 		$460K Buy
22,536
+20,136
+839% +$391K ﹤0.01% 3368
2015
Q4 		$49K Buy
+2,400
New +$48K ﹤0.01% 3919

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JP Morgan Chase's IHI Position: Q2 2026 in Review

JP Morgan Chase increased its iShares US Medical Devices ETF (IHI) stake by 3.8% in Q2 2026, buying an estimated $274K and bringing the position to 149,105 shares worth $7.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

JP Morgan Chase first reported a position in IHI in Q4 2015 and has held it in 43 quarters since. The position peaked at $165M in Q4 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • JP Morgan Chase held 149,105 shares of iShares US Medical Devices ETF worth $7.56M as of Q2 2026.
  • JP Morgan Chase bought 5,395 iShares US Medical Devices ETF shares in Q2 2026, an estimated $274K.
  • iShares US Medical Devices ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3065 holding.
  • JP Morgan Chase first reported a position in iShares US Medical Devices ETF in Q4 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's iShares US Medical Devices ETF position peaked at $165M in Q4 2021.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.